Cargando…
CREB Targets Define the Gene Expression Signature of Malignancies Having Reduced Levels of the Tumor Suppressor Tristetraprolin
The RNA-binding protein Tristetraprolin (TTP, ZFP36) functions as a tumor suppressor that impairs the development and disables the maintenance of MYC-driven lymphoma. In addition, other human cancers expressed reduced levels of TTP, suggesting that it may function as a tumor suppressor in several ma...
Autores principales: | Fallahi, Mohammad, Amelio, Antonio L., Cleveland, John L., Rounbehler, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277357/ https://www.ncbi.nlm.nih.gov/pubmed/25541715 http://dx.doi.org/10.1371/journal.pone.0115517 |
Ejemplares similares
-
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function
por: Berglund, Anders E., et al.
Publicado: (2016) -
Tristetraprolin limits age-related expansion of myeloid-derived suppressor cells
por: Kwack, Kyu Hwan, et al.
Publicado: (2022) -
Roles of Tristetraprolin in Tumorigenesis
por: Park, Jeong-Min, et al.
Publicado: (2018) -
Role of Tristetraprolin in the Resolution of Inflammation
por: Rappl, Peter, et al.
Publicado: (2021) -
Tristetraprolin Promotes Hepatic Inflammation and Tumor Initiation but Restrains Cancer Progression to Malignancy
por: Dolicka, Dobrochna, et al.
Publicado: (2020)